RecruitingPhase 2NCT05140148

Promoting Recovery After STroke With Amantadine

Sponsor

University of Pennsylvania

Enrollment

60 participants

Start Date

Feb 1, 2022

Study Type

INTERVENTIONAL

Conditions

Stroke, Ischemic Stroke Hemorrhagic

Summary

The investigators aim to examine whether amantadine can help patients recover from stroke. This will be a blinded randomized clinical trial (RCT). Patients will be randomized post-ischemic or hemorrhagic stroke either to the placebo arm or amantadine arm. Patients will be on study drug or placebo for 1 month but will be enrolled for 3 months total. At various time points patients will be examined and fill out questionnaires to determine level of stroke recovery.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Amantadine and a drug called Placebo for people with stroke hemorrhagic and stroke, ischemic. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.